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INVITED COMMENTS
At two national conferences in November 1997,
the American Heart Association conference and the
Montefiore Medical Center Current Issues and
Techniques in Interventional Radiology conference,
the treatment of carotid atherosclerosis by carotid
angioplasty and stenting was represented by promi-
nent speakers as a proven form of treatment. The
speakers recommended that this new treatment for
the prevention of stroke be used by cardiologists and
interventional radiologists because the results are
known to be safe and cost-effective. This view
appears to be held increasingly by specialists who use
catheter-based therapy as the only form of interven-
tional or procedural therapy in vascular disease. 
Specialty partisanship is a poor basis for recom-
mendation of treatment to patients, especially if the
partisanship is motivated by turf-control issues or
economic anxiety. The best foundation for perspec-
tive on a new therapy is scrutiny of the best avail-
able scientific evidence. This familiar process has
served well for a long time. What evidence is avail-
able now to form a conclusion about carotid stent-
ing? A peer-reviewed, externally adjudicated, ran-
domized trial has never compared carotid stenting
and carotid endarterectomy. The experience that
has been reported can be classified into the follow-
ing three categories: abstracts, anecdotal reports,
and clinical series. 
Many reports are available only in abstract form.
These reports usually have been accompanied by
verbal presentations at scientific meetings where per-
sonality and audiovisual aids also influence the mes-
sage. For example, a large carotid stent series from
Europe with more than 600 cases was presented ver-
bally and summarized only in abstract form. Such a
large amount of clinical information cannot be ade-
quately described so briefly. Yet, this particular series
is cited frequently during public discussions of
carotid stenting.
Two abstracts on carotid stenting from the
American Heart Association meeting illustrate how
brief reports provide incomplete evidence. One
study compared two groups of patients who received
bilateral carotid stenting either simultaneously at a
single procedure or sequentially by staged proce-
dures.1 Two strokes and one death occurred in the
first group, and four strokes occurred in the second
group. The authors concluded that “bilateral carotid
stenting can be successfully performed during the
same procedure” and that the “risk of neurologic
complications is not higher when compared with
staged procedures.” An alternative analysis might
conclude that because bilateral carotid stenting
yielded six strokes and one death in the total of 42
patients, bilateral carotid stenting is unacceptably
dangerous whether staged or simultaneous. No
details are available to help understand how the
authors could conclude that this experience was
“successful.”
In another presentation, comparison was made
between carotid stenting and carotid endarterectomy
in patients who were more than 80 years old.2 In the
group of 30 patients who underwent stenting there
were one major stroke, three minor strokes, and one
death. In the group that underwent endarterectomy
there were no strokes or deaths, but there were three
temporary cranial nerve palsies. The following con-
clusions were made: “1. Minor neurologic complica-
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tions (minor stroke and cranial nerve palsies) are
comparable,” and “2. Even though the stented
patients had higher co-morbidity, the non-neurolog-
ical complications were lower and the hospital stay
was shorter compared to patients undergoing
endarterectomy.” An alternative analysis would be
that cranial nerve palsy and minor stroke have not
been counted as equal endpoints in previous studies.
By the usual stroke and death endpoints, carotid
endarterectomy was significantly more successful
than stenting (p = 0.024, Fisher’s exact test). Again,
we should await a detailed report before we draw
conclusions. Although abstracts and verbal presenta-
tions play an important role in the process of infor-
mation distribution, they nevertheless do not provide
the best level of scientific evidence to draw conclu-
sions regarding the safest remedy for serious condi-
tions, such as those that threaten stroke. 
From 1983 to the present, many manuscripts
that appeared in all types of journals have reported
groups of patients treated by a variety of catheter-
based procedures. The following problems exist
with these reports: in general, the number of
patients treated is small; the data that describe their
condition are incomplete; the process used to select
for this type of intervention is not described; and
outcome beyond the immediate time of the proce-
dure is not provided. Perhaps the greatest difficulty
with these anecdotal reports is their tendency to
group together patients with different types of
lesions and dissimilar natural histories or stroke risks.
Thus anecdotes in a collection remain anecdotes
even with larger numbers. Still, such reports do have
value: they at least show technical feasibility, and
they help lead to more systematic examinations at
higher levels of evidence. However, the reports do
not provide the best level of evidence themselves.
Few reports of carotid stenting published in
complete manuscript form describe patient charac-
teristics, indications for treatment, and objectively
assessed results.3-7 These clinical series have come
from single institutions, and the participants have
described their own results. Sometimes these same
investigators have been involved with the develop-
ment of medical devices that pertain to carotid stent-
ing. They cannot be expected to be free of bias
under such circumstances. 
Now, in 1997, we have entered an era of indus-
try-sponsored trials of carotid stenting devices. At
least four such trials are open in the United States,
and others exist in Europe. Some of these trials are
designed to directly compare carotid stenting with
carotid endarterectomy, and other trials function, at
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least initially, as registries to document safety and
efficacy issues. An industry-sponsored trial may yield
well-documented data and certainly involves outside
review of results. Nevertheless, the focus of this type
of trial is different from that of a trial funded by an
independent agency with an external peer review.
Although an industry-sponsored trial may be
scrupulously organized and may include an end-
points adjudication committee and a data safety and
monitoring board, the trial nevertheless is aimed at
getting a product to market. Such a study, no mat-
ter how carefully executed, cannot be expected to
provide the best level of evidence because of the
overlying intention to support the development of
commercial enterprise. 
In 1997, two proposals were submitted to the
National Institutes of Health (NIH) for randomized
trials to compare carotid endarterectomy and carotid
stenting, Carotid Revascularization Endarterectomy
versus Stent Trial (CREST) and Carotid Artery
Stenting versus Endarterectomy Trial (CASET).
Each proposal was offered by an interspecialty group
of physicians with expertise in cerebrovascular dis-
ease and clinical investigations. The process of
review is ongoing. The process is complex partly
because the two proposals are from separate groups.
Major issues include establishment of a level of pro-
cedural expertise required to most safely apply
catheter-based therapy, anticipated changes in the
relevant medical devices, and consensus on whether
clinical equipoise exists to the extent required to
ethically randomize patients between the two treat-
ments.
Consideration of these difficult and critically
important issues takes time. Meanwhile, the promo-
tion of carotid stenting at many continuing-educa-
tion programs and the expanding experience of insti-
tutions that participate in industry-sponsored trials
continues. These forces conceivably may generate so
much enthusiasm and momentum for carotid stent-
ing that the procedure may become accepted prac-
tice without the best level of evidence available.
In this event, comparison to the history of carotid
endarterectomy may be drawn. The fundamental
premise for two prominent NIH-sponsored trials 
on carotid endarterectomy, the North American
Symptomatic Carotid Endarterectomy Trial8 and
Asymptomatic Carotid Atherosclerosis Study9 was
that the procedure had come into general use with-
out the support of the best level of evidence. The lack
of such evidence lead to contentious differences of
opinion among specialties about the proper place of
carotid endarterectomy during the 1970s and 1980s.
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Patients were not served well by conflicting advice
about the safest course of action. Will carotid stent-
ing repeat this history? 
Major patient morbidity rates and enormous
financial costs are at stake in the management of
carotid disease. An effort to acquire the best level of
evidence as soon as possible would be the most ben-
eficial for patient care and conservation of health
care resources. The proponents of randomized clin-
ical trials between carotid endarterectomy and
carotid stenting should meet the requirements of the
NIH so that a properly funded trial can be approved
quickly. We need to have the best level of evidence
before we draw conclusions.
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